Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients.
Rodríguez N, Gassó P, Martínez-Pinteño A, Segura ÀG, Mezquida G, Moreno-Izco L, González-Peñas J, Zorrilla I, Martin M, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibáñez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S; 2EPS group. Rodríguez N, et al. Among authors: segura ag. Schizophrenia (Heidelb). 2022 Apr 27;8(1):45. doi: 10.1038/s41537-022-00215-1. Schizophrenia (Heidelb). 2022. PMID: 35853879 Free PMC article.
Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene.
Segura AG, Mitjans M, Fatjó-Vilas M, Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Bobes-Bascaran T, de la Fuente-Tomás L, Velasco Iglesias A, Martínez-Cao C, González-Blanco L, Dal Santo F, Elizagarate E, Saiz PA, Fañanás L, Bobes J, Arias B. Segura AG, et al. Schizophr Res. 2020 Aug;222:516-519. doi: 10.1016/j.schres.2020.05.024. Epub 2020 Jun 14. Schizophr Res. 2020. PMID: 32553632 No abstract available.
Epigenetic clocks in relapse after a first episode of schizophrenia.
Segura ÀG, Prohens L, Mezquida G, Amoretti S, Bioque M, Ribeiro M, Gurriarán-Bas X, Rementería L, Berge D, Rodriguez-Jimenez R, Roldán A, Pomarol-Clotet E, Ibáñez A, Usall J, García-Portilla MP, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S; 2EPS group. Segura ÀG, et al. Schizophrenia (Heidelb). 2022 Jul 22;8(1):61. doi: 10.1038/s41537-022-00268-2. Schizophrenia (Heidelb). 2022. PMID: 35869075 Free PMC article.
The polygenic basis of relapse after a first episode of schizophrenia.
Segura ÀG, Prohens L, Gassó P, Rodríguez N, Garcia-Rizo C, Moreno-Izco L, Andreu-Bernabeu Á, Zorrilla I, Mane A, Rodriguez-Jimenez R, Roldán A, Sarró S, Ibáñez Á, Usall J, Sáiz PA, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S, Mezquida G, Arbelo N, De Matteis M, Galvañ J, Duque Guerra A, Arias I Queralt L, Perez-Bacigalupe M, Gonzalez-Ortega I, Toll A, Casanovas F, Sanchez-Pastor L, Valtueña M, Pomarol-Clotet E, García-León MÁ, Butjosa A, Rubio-Abadal E, Ribeiro M, López-Ilundain JM, Saiz-Ruiz J, León-Quismondo L, Rivero O, Ruiz P, Echevarría RS, García-Portilla MP. Segura ÀG, et al. Eur Neuropsychopharmacol. 2023 Oct;75:80-92. doi: 10.1016/j.euroneuro.2023.06.003. Epub 2023 Aug 19. Eur Neuropsychopharmacol. 2023. PMID: 37603902 Free article.
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
Prohens L, Rodríguez N, Segura ÀG, Martínez-Pinteño A, Olivares-Berjaga D, Martínez I, González A, Mezquida G, Parellada M, Cuesta MJ, Bernardo M, Gassó P, Mas S. Prohens L, et al. Among authors: segura ag. Psychiatry Res. 2024 Feb;332:115722. doi: 10.1016/j.psychres.2024.115722. Epub 2024 Jan 5. Psychiatry Res. 2024. PMID: 38198858 Free article.
Cranial CT scan in transient global amnesia.
Matias-Guiu J, Colomer R, Segura A, Codina A. Matias-Guiu J, et al. Acta Neurol Scand. 1986 Mar;73(3):298-301. doi: 10.1111/j.1600-0404.1986.tb03280.x. Acta Neurol Scand. 1986. PMID: 3716770
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls.
Segura AG, Serna E, Sugranyes G, Baeza I, Valli I, Martínez-Serrano I, Díaz-Caneja CM, Andreu-Bernabeu Á, Moreno DM, Gassó P, Rodríguez N, Martínez-Pinteño A, Prohens L, Torrent C, García-Rizo C, Mas S, Castro-Fornieles J. Segura AG, et al. Eur Neuropsychopharmacol. 2024 Apr;81:28-37. doi: 10.1016/j.euroneuro.2024.01.009. Epub 2024 Feb 6. Eur Neuropsychopharmacol. 2024. PMID: 38310718 Free article.
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort.
Segura AG, Mané A, Prohens L, Rodriguez N, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, González-Pinto A, Diaz-Caneja CM, Bejarano AR, Jimenez E, Baeza I, Legido T, Saiz-Ruiz J, Bernardo M, Mas S; PEPs Group. Segura AG, et al. Psychiatry Res. 2023 Jul;325:115249. doi: 10.1016/j.psychres.2023.115249. Epub 2023 May 9. Psychiatry Res. 2023. PMID: 37178502 Free article.
21 results